Juan P. Yarzabal
Rixensart, WAL, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies - A stakeholder meeting report.
Journal: Biologicals : journal of the International Association of Biological Standardization
Published: September 25, 2024
Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study.
Journal: The Journal of infectious diseases
Published: February 29, 2024
Bacterial nasopharyngeal carriage following infant immunization with pneumococcal conjugate vaccines according to a 2+1 schedule in children in South Africa: an exploratory analysis of two clinical trials.
Journal: Expert review of vaccines
Published: November 27, 2020
Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans.
Journal: Vaccine
Published: September 12, 2018
Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial.
Journal: Expert review of vaccines
Published: April 21, 2017
Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trial.
Journal: Human vaccines & immunotherapeutics
Published: April 04, 2017
Safety assessment of adjuvanted vaccines: Methodological considerations.
Journal: Human vaccines & immunotherapeutics
Published: June 02, 2015
Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study.
Journal: Human vaccines & immunotherapeutics
Published: May 29, 2015
Immunogenicity, safety and reactogenicity of the 10-valent pneumococcal non-typeable haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian Infants: a randomised trial.
Journal: The Nigerian postgraduate medical journal
Published: March 18, 2014
Safety and immunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of life.
Journal: Human vaccines & immunotherapeutics
Published: December 21, 2013
Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial.
Journal: PLoS medicine
Published: September 03, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026